Mead Johnson Nutrition CO (MJN) : Boussard Gavaudan Investment Management Llp scooped up 32,923 additional shares in Mead Johnson Nutrition CO during the most recent quarter end , the firm said in a disclosure report filed with the SEC on May 2, 2016. The investment management firm now holds a total of 298,120 shares of Mead Johnson Nutrition CO which is valued at $25,355,106.Mead Johnson Nutrition CO makes up approximately 14.12% of Boussard Gavaudan Investment Management Llp’s portfolio.
Mead Johnson Nutrition CO opened for trading at $84.66 and hit $85.46 on the upside on Friday, eventually ending the session at $85.05, with a gain of 0.15% or 0.13 points. The heightened volatility saw the trading volume jump to 5,99,858 shares. Company has a market cap of $15,876 M.
Other Hedge Funds, Including , Rhumbline Advisers reduced its stake in MJN by selling 11,004 shares or 3.45% in the most recent quarter. The Hedge Fund company now holds 307,588 shares of MJN which is valued at $26,160,359. Mead Johnson Nutrition CO makes up approx 0.08% of Rhumbline Advisers’s portfolio. St. Johns Investment Management Company sold out all of its stake in MJN during the most recent quarter. The investment firm sold 60 shares of MJN which is valued $5,229.Washington Trust Bank boosted its stake in MJN in the latest quarter, The investment management firm added 8,783 additional shares and now holds a total of 34,502 shares of Mead Johnson Nutrition CO which is valued at $3,006,849. Mead Johnson Nutrition CO makes up approx 0.76% of Washington Trust Bank’s portfolio.First Manhattan Co reduced its stake in MJN by selling 5,000 shares or 15.53% in the most recent quarter. The Hedge Fund company now holds 27,186 shares of MJN which is valued at $2,280,905. Mead Johnson Nutrition CO makes up approx 0.01% of First Manhattan Co’s portfolio.Wealth Enhancement Advisory Services boosted its stake in MJN in the latest quarter, The investment management firm added 2,888 additional shares and now holds a total of 14,606 shares of Mead Johnson Nutrition CO which is valued at $1,225,443. Mead Johnson Nutrition CO makes up approx 0.24% of Wealth Enhancement Advisory Services’s portfolio.
On the company’s financial health, Mead Johnson Nutrition CO reported $0.87 EPS for the quarter, beating the analyst consensus estimate by $ 0.03 according to the earnings call on Apr 28, 2016. Analyst had a consensus of $0.84. The company had revenue of $962.10 million for the quarter, compared to analysts expectations of $954.99 million. The company’s revenue was down -12.1 % compared to the same quarter last year.During the same quarter in the previous year, the company posted $1.09 EPS.
Many Wall Street Analysts have commented on Mead Johnson Nutrition CO. Mead Johnson Nutrition CO was Upgraded by Credit Suisse to ” Outperform” on Mar 16, 2016.
Mead Johnson Nutrition Company (Mead Johnson) is a global pediatric nutrition company. The Company manufactures distributes and sells infant formulas children’s nutrition and other nutritional products. Its product portfolio includes routine and specialty infant formulas childrens milks and milk modifiers dietary supplements for pregnant and breastfeeding mothers pediatric vitamins and products for pediatric metabolic disorders. The Company operates through three segments: Asia Latin America and North America/Europe. The Company’s Enfa family of brands including Enfamil infant formula is a brand franchise in pediatric nutrition. Its product portfolio addresses a range of nutritional needs for infants children and expectant and nursing mothers. The Company markets its portfolio of more than 70 products to mothers healthcare professionals and retailers in more than 50 countries in Asia North America Latin America and Europe.